Trademarkia Logo

Canada

C$
QPARIK
ADVERTISED

on 15 Jan 2025

Last Applicant/ Owned by

Incyte Holdings Corporation

1801 Augustine Cut-OffWilmington DE 19803

US

Serial Number

2225555 filed on 3rd Nov 2022

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

QPARIK

Trademark usage description

pharmaceutical preparations for the treatment of oncological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharma Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of oncological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment graft versus host disorders.


Classification kind code

11

Class [016]
Printed publications, namely, brochures, newsletters, and pamphlets relating to medical healthcare issues, procedures, disease symptoms and treatments, patient support and community building.


Classification kind code

11

Class [044]
Providing healthcare information to physicians, patients and caregivers relating to diagnosis and treatment of oncological disorders, auto-immune disorders, hematological disorders and graft versus host disorder.


Classification kind code

11

Mark Details


Serial Number

2225555

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 13th Mar 2024
Search Recorded
Submitted for opposition 20
on 13th Mar 2024
Examiner's First Report
Submitted for opposition 223
on 13th Mar 2024
Total Provisional Refusal
Submitted for opposition 256
on 2th Oct 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 14th Dec 2022
Agent Changed
Submitted for opposition 257
on 1st Dec 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 30th Nov 2022
Created
Submitted for opposition 31
on 30th Nov 2022
Formalized
Submitted for opposition 30
on 3rd Nov 2022
Filed
Submitted for opposition 228
on 3rd Nov 2022
International Registration